Investors who are currently on the hunt for penny stocks could consider having a closer look at the Enzolytics Inc (OTC: ENZC) stock. The penny stock has been on a remarkable run in recent days and on Monday it rallied by another 41% as investors continued to pile onto it.
In 2021 so far, the stock has rallied by as high as 950% to emerging as one of the top gainers from among penny stocks. In such a scenario, it might be important to have a closer look at the company and its business.
Enzolytics is best known for having acquired the license for Irreversible Pepsin Fraction peptide molecule. It is meant for treating HIV and that could be one of the reasons behind the optimism around the stock. The company also claims that the product in question does not cause any side effects and is devoid of harmful toxins. The market could be worth as large as $37 billion by 2027.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.